HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P J Middlemiss Selected Research

4- ((3- (1,6- dihyro- 6- oxo- 9H- purin- 9- yl)- 1- oxopropyl)amino)benzoic acid

9/2004AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats.
6/2001AIT-082 is neuroprotective against kainate-induced neuronal injury in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P J Middlemiss Research Topics

Disease

2Body Weight (Weight, Body)
09/2004 - 06/2001
1Gliosis
09/2004
1Spinal Cord Compression
09/2004
1Spinal Cord Injuries (Spinal Cord Injury)
09/2004
1Seizures (Absence Seizure)
06/2001
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2001
1Status Epilepticus (Complex Partial Status Epilepticus)
06/2001

Drug/Important Bio-Agent (IBA)

24- ((3- (1,6- dihyro- 6- oxo- 9H- purin- 9- yl)- 1- oxopropyl)amino)benzoic acidIBA
09/2004 - 06/2001
1purineIBA
09/2004
1MethylprednisoloneFDA LinkGeneric
09/2004
1Benzoic Acid (Potassium Benzoate)FDA Link
09/2004
1Diazepam (Valium)FDA LinkGeneric
06/2001
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
06/2001
1Kainic Acid (Kainate)IBA
06/2001

Therapy/Procedure

1Investigational Therapies (Experimental Therapy)
06/2001